$17.71▾ 0.95%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$-17.99MTTM operating cash
Pre-profit
It is still burning cash while pre-profit.
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Highdebt to assets
Weak
High leverage relative to its assets.
More coming: dilution / share-count creep.
✦ The read
Eloxx Pharmaceuticals, Inc. is pre-profit. It is still burning cash while pre-profit. High leverage relative to its assets.
Key numbers
Valuation
EPS (TTM)$-22.46
TTM (trailing 12 months, through fiscal Q3 FY2023)
Size
Revenue (TTM)$0.00
TTM (trailing 12 months, through fiscal Q3 FY2023)
Signals and key numbers are from the fiscal Q3 FY2023 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.